Form EFFECT LENZ Therapeutics, Inc.
Tweet
Share
E-mail| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | April 14, 2025 4:00 P.M. |
| Form: | S-3 | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ELEKTROS Highlights 23.40% Market Gain While Continuing to Build Its Vision for America's High-Speed EV Future
- As U.S. Markets Reach New Highs, Publicly Traded ELEKTROS (OTC Pink:ELEK) Reports Strong Trading Session and Operational Progress
- Health Endeavors Launches AI Care Suite and Secures Growth Investment from Decathlon Capital Partners
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
